ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 148 filers reported holding ACCELERON PHARMA INC in Q4 2016. The put-call ratio across all filers is 3.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $3,942,000 | -23.8% | 84,655 | -28.8% | 0.00% | -25.0% |
Q4 2018 | $5,175,000 | -62.6% | 118,830 | -50.8% | 0.00% | -20.0% |
Q3 2018 | $13,824,000 | +177.1% | 241,568 | +135.0% | 0.01% | +66.7% |
Q2 2018 | $4,988,000 | +47.0% | 102,798 | +18.4% | 0.00% | +50.0% |
Q1 2018 | $3,394,000 | -8.1% | 86,811 | -0.2% | 0.00% | 0.0% |
Q4 2017 | $3,693,000 | +18.0% | 87,027 | +3.8% | 0.00% | 0.0% |
Q3 2017 | $3,129,000 | +19.4% | 83,849 | -2.7% | 0.00% | 0.0% |
Q2 2017 | $2,620,000 | +0.2% | 86,211 | -12.7% | 0.00% | 0.0% |
Q1 2017 | $2,614,000 | +30.4% | 98,743 | +25.7% | 0.00% | +100.0% |
Q4 2016 | $2,005,000 | -33.8% | 78,554 | -6.1% | 0.00% | -50.0% |
Q3 2016 | $3,029,000 | -11.0% | 83,696 | -16.5% | 0.00% | -33.3% |
Q2 2016 | $3,405,000 | +44.0% | 100,192 | +11.8% | 0.00% | +50.0% |
Q1 2016 | $2,364,000 | -30.1% | 89,587 | +29.2% | 0.00% | -33.3% |
Q4 2015 | $3,380,000 | +90.3% | 69,324 | -2.8% | 0.00% | +200.0% |
Q3 2015 | $1,776,000 | -23.2% | 71,333 | -2.4% | 0.00% | -50.0% |
Q2 2015 | $2,312,000 | +5.8% | 73,059 | +27.3% | 0.00% | 0.0% |
Q1 2015 | $2,185,000 | -2.3% | 57,406 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $2,237,000 | +22.9% | 57,406 | -4.6% | 0.00% | +100.0% |
Q3 2014 | $1,820,000 | -27.1% | 60,188 | -18.1% | 0.00% | -50.0% |
Q2 2014 | $2,497,000 | +94.9% | 73,515 | +97.9% | 0.00% | +100.0% |
Q1 2014 | $1,281,000 | -34.1% | 37,141 | -24.3% | 0.00% | 0.0% |
Q4 2013 | $1,943,000 | – | 49,070 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |